SC
ABBV icon

Sapient Capital’s AbbVie ABBV Stock Holding History

Sapient Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.4M Sell
196,236
-8,705
-4% -$1.87M 0.65% 22
2026
Q1 		$44.6M Sell
204,941
-15,994
-7% -$3.55M 0.67% 24
2025
Q4 		$50.7M Buy
220,935
+984
+0.4% +$224K 0.71% 22
2025
Q3 		$49.1M Sell
219,951
-8,543
-4% -$1.74M 0.76% 22
2025
Q2 		$42.4M Sell
228,494
-1,594
-0.7% -$296K 0.76% 27
2025
Q1 		$48.2M Sell
230,088
-28,811
-11% -$5.6M 0.95% 20
2024
Q4 		$46M Buy
258,899
+3,404
+1% +$626K 0.88% 21
2024
Q3 		$50.5M Buy
255,495
+6,258
+3% +$1.17M 1.01% 18
2024
Q2 		$42.7M Sell
249,237
-18,767
-7% -$3.11M 0.89% 20
2024
Q1 		$48.8M Sell
268,004
-55,328
-17% -$9.54M 1.08% 18
2023
Q4 		$50.1M Buy
+323,332
New +$47.1M 1.29% 14

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Sapient Capital's ABBV Position: Q2 2026 in Review

Sapient Capital reduced its AbbVie (ABBV) stake by 4.2% in Q2 2026, selling an estimated $1.87M and leaving 196,236 shares worth $49.4M. The position accounts for 0.65% of the portfolio, ranked #22.

Sapient Capital first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $50.7M in Q4 2025. 2,119 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sapient Capital held 196,236 shares of AbbVie worth $49.4M as of Q2 2026.
  • Sapient Capital sold 8,705 AbbVie shares in Q2 2026, an estimated $1.87M.
  • AbbVie made up 0.65% of Sapient Capital's portfolio in Q2 2026, its #22 holding.
  • Sapient Capital first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • Sapient Capital's AbbVie position peaked at $50.7M in Q4 2025.
  • 2,119 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.